Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Influenza
Meningococcal disease
SAGE documentation
Scientific publications
2015
2012
Clear all
Type of publications
NITAG documentation
(26)
SAGE documentation
(17)
Scientific publications
(2)
Systematic reviews (SYSVAC)
(38)
Topics
GRADE table
(15)
Position paper
(1)
Available to download in languages
English (EN)
(19)
French (FR)
(2)
Regions
Africa
(2)
Countries
Diseases
Influenza
(12)
Meningococcal disease
(7)
Haemophilus influenzae type B
(1)
Hepatitis A
(6)
Human papillomavirus (HPV)
(2)
Japanese encephalitis
(10)
Malaria
(2)
Pertussis
(4)
Pneumococcal disease
(1)
Vaccine topics
Target population
Children
(1)
Healthcare workers
(2)
Newborn
(3)
Older adults
(1)
Pregnant women
(1)
Risk group
(2)
Publication date
2015
(7)
2012
(12)
2024
(1)
2022
(3)
2020
(1)
2019
(1)
2018
(2)
2016
(1)
2014
(1)
2011
(1)
19 results found
2015
∙
Milagritos D. Tapia, Samba O. Sow, Fadima Cheick Haidara, Fatoumata Diallo, Moussa Doumbia, Godwin C. Enwere, Gandhali Paranjape, Jacques Hervé, Marie-Pierre Préziosi
A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians
2015
∙
Andromachi Karachaliou, Andrew J. K. Conlan, Marie-Pierre Préziosi, Caroline Trotter
Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
2015
∙
WHO
Meningococcal A conjugate vaccine: updated guidance
2015
∙
SAGE
Duration of protection conferred by MenA conjugate vaccination in immunocompetent children (3 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a single-dose MenA conjugate vaccination in immunocompetent children (9 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a two dose schedule of MenA conjugate vaccination in immunocompetent children (3 to 9 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Safety of MenA conjugate vaccination in immunocompetent children (3 to 24 months of age)
2012
∙
SAGE
Grading of scientific evidence for individuals aged 65 years or more
2012
∙
SAGE
Grading of scientific evidence for children aged 2 to 6 years
2012
∙
SAGE
Grading of scientific evidence for health care workers
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register